221
Participants
Start Date
June 18, 2018
Primary Completion Date
June 21, 2019
Study Completion Date
September 12, 2024
Belantamab mafodotin frozen liquid
Belantamab mafodotin will be available as frozen liquid. Frozen liquid will be available as 30 milligram (mg)/vial solution in a single use vial with unit dose strength of 2.5 or 3.4 mg/kg. Belantamab mafodotin will be administered as IV solution over at least 30 minutes. Frozen belantamab mafodotin will be diluted in 0.9 percent saline and administered via infusion pump.
Belantamab mafodotin lyophilized powder
Belantamab mafodotin will be available as lyophilized powder. Lyophilized powder will be available as 100 mg/vial in single-use vial for reconstitution with unit dose strength of 3.4 mg/kg. Lyophilized belantamab mafodotin will be reconstituted using water for injection and diluted with saline before use.
GSK Investigational Site, Melbourne
GSK Investigational Site, Fitzroy
GSK Investigational Site, Woodville
GSK Investigational Site, New York
GSK Investigational Site, New York
GSK Investigational Site, Torino
GSK Investigational Site, Granada
GSK Investigational Site, Schwerin
GSK Investigational Site, Philadelphia
GSK Investigational Site, Baltimore
GSK Investigational Site, Madrid
GSK Investigational Site, Charlotte
GSK Investigational Site, Madrid
GSK Investigational Site, Murcia
GSK Investigational Site, Atlanta
GSK Investigational Site, Atlanta
GSK Investigational Site, Hanover
GSK Investigational Site, PamplonaNavarra
GSK Investigational Site, Toulouse
GSK Investigational Site, Aviano PN
GSK Investigational Site, Pessac
GSK Investigational Site, Salamanca
GSK Investigational Site, Nashville
GSK Investigational Site, Parma
GSK Investigational Site, Columbus
GSK Investigational Site, Nantes
GSK Investigational Site, Valencia
GSK Investigational Site, Indianapolis
GSK Investigational Site, Madison
GSK Investigational Site, Rochester
GSK Investigational Site, Koblenz
GSK Investigational Site, Lille
GSK Investigational Site, Chicago
GSK Investigational Site, Chicago
GSK Investigational Site, Fairway
GSK Investigational Site, Pierre-Bénite
GSK Investigational Site, Baton Rouge
GSK Investigational Site, Tübingen
GSK Investigational Site, Paris
GSK Investigational Site, Houston
GSK Investigational Site, Salt Lake City
GSK Investigational Site, Rionero in Vulture PZ
GSK Investigational Site, Würzburg
GSK Investigational Site, Seattle
GSK Investigational Site, New Haven
GSK Investigational Site, Boston
GSK Investigational Site, Calgary
GSK Investigational Site, Winnipeg
GSK Investigational Site, Toronto
GSK Investigational Site, Dresden
GSK Investigational Site, Badalona
GSK Investigational Site, Barcelona
GSK Investigational Site, Birmingham
GSK Investigational Site, Bournemouth
GSK Investigational Site, London
GSK Investigational Site, Nottingham
GSK Investigational Site, Oxford
GSK Investigational Site, Stoke-on-Trent
GSK Investigational Site, Sutton
Lead Sponsor
GlaxoSmithKline
INDUSTRY